Brazilian hematology consensus sets referral thresholds for palliative care
Palliative care in hematologic disease is no longer a peripheral concern reserved for the final days of life. The Brazilian Association of Hematology, Hemotherapy and Cell Therapy issued a consensus focused on referral criteria for pediatric and adult patients with blood disorders, placing symptom relief, family support, and specialty integration at the center of care planning.
The document is anchored in a simple clinical truth: patients with hematologic diseases often live with prolonged treatment courses, recurrent complications, and unpredictable trajectories that can shift rapidly from stability to crisis. In that setting, palliative care is not synonymous with treatment withdrawal. It is a parallel layer of care aimed at easing physical pain, psychological distress, social strain, and spiritual suffering while disease-directed therapy continues when appropriate.
The consensus also frames palliative care as a professional obligation rather than an optional add-on. That stance matters in hematology, where transfusion dependence, infection risk, bleeding, mucosal toxicity, and treatment-related fatigue can accumulate long before a terminal phase is recognized. Early involvement can help clinicians align interventions with patient goals and reduce avoidable suffering.
Why hematologic disease creates a different palliative care problem
Blood cancers and nonmalignant hematologic disorders can follow some of the most clinically unstable trajectories in medicine. A patient may appear well enough for outpatient care one week and then face an acute hospitalization for sepsis, bleeding, or severe anemia the next. This volatility makes prognostication difficult and often delays conversations about symptom control and goals of care.
Pediatric patients add another layer of complexity. Families must navigate fear, uncertainty, and developmentally specific burdens while clinicians balance curative intent, toxicity, and the emotional weight of prolonged therapy. Adult patients face a different but equally difficult calculus when chronic relapsing disease, transplant candidacy, or repeated lines of therapy erode function and quality of life.
In that context, referral to specialized palliative care teams serves several purposes at once. It can improve symptom assessment, provide structured communication support, and create continuity when the treating hematology team is managing transfusions, chemotherapy, immunosuppression, or cellular therapy. The consensus places those needs inside the core workflow of hematologic care rather than at the end of it.
One sentence captures the practical reality: symptom burden should trigger referral before the disease trajectory becomes irreversible.
Referral should follow burden, not prognosis alone
The consensus was designed to establish recommendations for when pediatric and adult hematologic patients should be referred to specialized palliative care and how the two specialties can work together. Although the abstract does not list individual thresholds, the clinical logic is clear: referral should be based on the presence of distress, disease complexity, and support needs rather than on prognostic certainty alone.
That approach reflects the limitations of hematology itself. Many patients have illnesses that fluctuate over months or years, making a single “terminal” moment difficult to identify. Waiting for a definitive decline can postpone help until symptoms are entrenched and the family is already in crisis. Earlier referral allows palliative clinicians to address nausea, pain, dyspnea, fatigue, anxiety, sleep disruption, and caregiver strain while there is still time to intervene meaningfully.
The integration question is especially important in high-intensity treatment settings. Patients undergoing repeated admissions, transplant evaluation, or intensive salvage therapy may benefit from palliative care involvement because these therapies often amplify physical toxicity and emotional distress. In that setting, palliative care does not compete with hematologic treatment; it stabilizes the human consequences of treatment.
Children, adults, and families require different conversations
Pediatric hematology demands careful attention to developmental stage, family structure, and shared decision-making. Children may not be able to articulate pain or existential distress in the same way adults do, and parents frequently carry the emotional burden of decision-making under pressure. Specialized palliative care teams can support communication around symptoms, treatment goals, and uncertainty while preserving trust.
Adult care brings its own challenges. Patients may be balancing work, caregiving duties, financial stress, and repeated hospital visits while confronting relapsed disease or cumulative toxicity. In these circumstances, palliative care can improve the consistency of counseling around symptom control and escalation planning. It also creates room for honest discussion when disease-modifying therapy is unlikely to restore the patient’s desired level of function.
The biological burden of hematologic illness helps explain why symptom-focused care is essential. Anemia can drain energy and worsen dyspnea. Thrombocytopenia raises bleeding risk. Neutropenia and immune dysfunction increase the threat of infection. Treatment itself can compound discomfort through mucositis, neuropathy, nausea, and fatigue. These are not secondary issues. They are direct consequences of the disease and its therapy, and they deserve dedicated management.
Integration of specialties can reduce fragmentation
The consensus points toward integration between hematology and palliative care rather than sequential handoff. In practice, that means the two teams should communicate early, share goals, and avoid framing palliative care as a signal of abandonment. When referral happens late, the handoff can feel abrupt and destabilizing. When it happens earlier, palliative clinicians can become part of the care structure before the first major crisis.
That model may be especially useful in settings where treatment options remain active but burdensome. Hematologic patients often need ongoing transfusions, infection surveillance, pain control, and repeated reassessment of treatment tolerance. Palliative care can help coordinate these moving parts while preserving patient preferences. It also gives families a clearer path when decisions become more complex and time-sensitive.
The consensus statement arrives at a moment when palliative care publications in hematology are increasing but still sparse. The field has recognized the need; the clinical gap remains in operationalizing when and how referrals should occur across pediatric and adult populations. This document directly addresses that gap by formalizing the conversation around referral criteria.
A consensus built on scarcity of data and high clinical need
The abstract makes clear that available data remain limited despite growing recognition of palliative care in hematologic disease. In the absence of large, definitive trials, consensus guidance often becomes the most practical tool available to clinicians. Here, the value lies in standardizing judgment where practice has often been inconsistent.
That is particularly relevant in hematology because the consequences of delay are visible at the bedside. Uncontrolled pain, breathlessness, refractory fatigue, caregiver distress, and repeated emergency visits can accumulate while teams continue to focus narrowly on disease-directed endpoints. A referral framework gives clinicians a way to identify patients who need support before suffering becomes entrenched.
The document does not present outcome data in the abstract, and it does not claim to answer every operational question. It does, however, set a clear direction: specialized palliative care should be considered an integral component of hematologic care for both children and adults when symptom burden, psychosocial distress, or disease complexity warrant it. The remaining work is implementation, especially across diverse care settings where access, staffing, and referral culture vary widely.